相关实验视频
Updated: Jan 16, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
染细胞瘤危机用乌拉皮迪尔治疗:一个案例报告
Miro Bakula1, Lea Tomašić2, Ivana Kokan2
1Sveti Duh University Hospital, Division of Endocrinology, Department of Internal Medicine, Zagreb, Croatia.
乳红细胞瘤危机是一种罕见的疾病,可由β-阻断剂触发. 这份病例报告强调了乌拉皮迪尔的成功治疗,强调了对这些罕见瘤的谨慎药物管理.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 在瘤学瘤学.
背景情况:
- 血红细胞瘤是一种罕见的神经内分泌瘤,引起各种症状和潜在的高血压危机.
- 色细胞瘤中catecholamine的过度生产可能导致严重的心血管并发症.
- 发酵细胞瘤危机的触发因素各不相同,需要谨慎的诊断和管理方法.
研究的目的:
- 报告一例因不使用α阻断剂而服用β阻断剂引起的色细胞瘤危机.
- 评估乌拉皮迪尔在治疗急性染细胞瘤危机中的疗效.
- 讨论乌拉皮迪尔在染色细胞瘤管理中的含义.
主要方法:
- 一个33岁的男性患者的病例报告,呈现出染细胞瘤危机.
- 治疗开始用高剂量乌拉皮迪尔用于血液动力学稳定.
- 在实现稳定的血液动力学后,过渡到氧胺.
主要成果:
- 患者经历了由β-阻断剂治疗引发的染细胞瘤危机.
- 高剂量的乌拉皮迪尔有效地稳定了患者的血液动力学.
- 在过渡到氧胺之前,乌拉皮迪尔在急性管理阶段成功使用.
结论:
- 叶红细胞瘤危机可以通过urapidil成功管理.
- 需要进一步研究乌拉皮迪尔在急性乳红细胞瘤危机和手术前管理中的作用.
- 适当的α-和β-阻塞测序对于管理染细胞瘤患者至关重要.
更多相关视频
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
相关概念视频
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Urinary Tract Calculi V: Nursing Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management